BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16287753)

  • 1. Confirmation of a role for the 389R>G beta-1 adrenoceptor polymorphism on exercise capacity in heart failure.
    Sandilands AJ; Parameshwar J; Large S; Brown MJ; O'Shaughnessy KM
    Heart; 2005 Dec; 91(12):1613-4. PubMed ID: 16287753
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure.
    Wagoner LE; Craft LL; Zengel P; McGuire N; Rathz DA; Dorn GW; Liggett SB
    Am Heart J; 2002 Nov; 144(5):840-6. PubMed ID: 12422153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GNAS A-1121G variant is associated with improved diastolic dysfunction in response to exercise training in heart failure patients.
    Alves AJ; Goldhammer E; Ribeiro F; Eynon N; Ben-Zaken Cohen S; Duarte JA; Viana JL; Sagiv M; Oliveira J
    Int J Sports Med; 2013 Mar; 34(3):274-80. PubMed ID: 23065660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha2C-adrenoceptor polymorphism is associated with improved event-free survival in patients with dilated cardiomyopathy.
    Regitz-Zagrosek V; Hocher B; Bettmann M; Brede M; Hadamek K; Gerstner C; Lehmkuhl HB; Hetzer R; Hein L
    Eur Heart J; 2006 Feb; 27(4):454-9. PubMed ID: 16299019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of beta1- and beta2-adrenoceptor polymorphisms in heart failure: a case-control study.
    Covolo L; Gelatti U; Metra M; Nodari S; Piccichè A; Pezzali N; Zani C; Alberti A; Donato F; Nardi G; Dei Cas L
    Eur Heart J; 2004 Sep; 25(17):1534-41. PubMed ID: 15342173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thr164Ile polymorphism of beta2-adrenergic receptor negatively modulates cardiac contractility: implications for prognosis in patients with idiopathic dilated cardiomyopathy.
    Barbato E; Penicka M; Delrue L; Van Durme F; De Bruyne B; Goethals M; Wijns W; Vanderheyden M; Bartunek J
    Heart; 2007 Jul; 93(7):856-61. PubMed ID: 17569809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Familial idiopathic dilated cardiomyopathy - search for identity].
    Tendera M
    Kardiol Pol; 2009 Mar; 67(3):242. PubMed ID: 19469061
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel variants in 3 kb of 5'UTR of the beta 1-adrenergic receptor gene (-93C>T, -210C>T, and -2146T>C): -2146C homozygotes present in patients with idiopathic dilated cardiomyopathy and coronary heart disease.
    Wenzel K; Felix SB; Bauer D; Heere P; Flachmeier C; Podlowski S; Köpke K; Hoehe MR
    Hum Mutat; 2000 Dec; 16(6):534. PubMed ID: 11102996
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of reduced muscle bulk on the ventilatory response to exercise in chronic congestive heart failure secondary to idiopathic dilated and ischemic cardiomyopathy.
    Harrington D; Clark AL; Chua TP; Anker SD; Poole-Wilson PA; Coats AJ
    Am J Cardiol; 1997 Jul; 80(1):90-3. PubMed ID: 9205030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure. A study on 686 consecutive patients.
    de Groote P; Mouquet F; Dallongeville J; Lamblin N; Bauters C
    Am Heart J; 2007 May; 153(5):e15. PubMed ID: 17452135
    [No Abstract]   [Full Text] [Related]  

  • 11. Polymorphisms of adrenergic receptors and the risk of heart failure.
    Meisel C; Köpke K; Roots I
    N Engl J Med; 2003 Jan; 348(5):468-70; author reply 468-70. PubMed ID: 12556550
    [No Abstract]   [Full Text] [Related]  

  • 12. β1- and α2C-adrenergic receptor polymorphisms and the antiarrhythmic effect of bucindolol in heart failure with reduced ejection fraction.
    Lymperopoulos A; Negussie S; Walklett K
    Pharmacogenomics; 2013 Oct; 14(13):1545-9. PubMed ID: 24088125
    [No Abstract]   [Full Text] [Related]  

  • 13. Polymorphisms of the beta-1 and beta-2 adrenergic receptors in Polish patients with idiopathic dilated cardiomyopathy.
    Paczkowska A; Szperl M; Małek Ł; Mazurkiewicz Ł; Skóra E; Grzybowski J; Roszczynko M; Bilińska Z; Tesson F; Ruzyłło W
    Kardiol Pol; 2009 Mar; 67(3):235-41. PubMed ID: 19378229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy.
    Magnusson Y; Levin MC; Eggertsen R; Nyström E; Mobini R; Schaufelberger M; Andersson B
    Clin Pharmacol Ther; 2005 Sep; 78(3):221-31. PubMed ID: 16153393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
    Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
    Lobmeyer MT; Gong Y; Terra SG; Beitelshees AL; Langaee TY; Pauly DF; Schofield RS; Hamilton KK; Herbert Patterson J; Adams KF; Hill JA; Aranda JM; Johnson JA
    Pharmacogenet Genomics; 2007 Apr; 17(4):277-82. PubMed ID: 17496726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy.
    Forleo C; Resta N; Sorrentino S; Guida P; Manghisi A; De Luca V; Romito R; Iacoviello M; De Tommasi E; Troisi F; Rizzon B; Guanti G; Rizzon P; Pitzalis MV
    Am J Med; 2004 Oct; 117(7):451-8. PubMed ID: 15464701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of adrenoceptors are not associated with an increased risk of adverse event in heart failure: a MERIT-HF substudy.
    Savva J; Maqbool A; White HL; Galloway SL; Yuldasheva NY; Ball SG; West RM; De Boer RA; Van Veldhuisen DJ; Balmforth AJ;
    J Card Fail; 2009 Jun; 15(5):435-41. PubMed ID: 19477404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beta1-adrenergic receptor (Arg389Gly) polymorphism and response to bisoprolol in patients with chronic heart failure].
    Yu WP; Lou M; Deng B; Song HM; Wang HB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):776-80. PubMed ID: 17217681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of beta-adrenoreceptor gene polymorphisms on survival in patients with congestive heart failure.
    de Groote P; Lamblin N; Helbecque N; Mouquet F; Mc Fadden E; Hermant X; Amouyel P; Dallongeville J; Bauters C
    Eur J Heart Fail; 2005 Oct; 7(6):966-73. PubMed ID: 16227135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.